1,750 results
Find out if (LLY) is in Cramer's Portfolio. Powered by its strong earnings growth of 56.04% and other important driving factors, this stock has surged by 37.27% over the past year, outperforming the rise in the S&P 500 Index during the same period.TheStreet.com · 5/21/2013
TheStreet reaffirmed their buy rating on shares of Eli Lilly & Co. (NYSE: LLY) in a research note released on Tuesday morning, AnalystRatings.Net reports. “Eli Lilly and Company (LLY) has been reiterated by TheStreet Ratings as a buy with a ...mideasttime.com · 1 day ago
Eli Lilly & Co. (NYSE: LLY)‘s stock had its “buy” rating reiterated by investment analysts at TheStreet in a note issued to investors on Tuesday, ARN reports. The analysts wrote, “Eli Lilly and Company (LLY) has been reiterated by TheStreet Ratings ...Daily Political · ByTyrone Williams · 5/21/2013
Confirmation bias – one of the psychological traps investors can be most prone to falling victim to. What happens to us as investors when we are influenced by this bias is we essentially discount all information that counters our established view point.INSIDER MONKEY · 5/15/2013
Eli Lilly and Company ( LLY) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on June 10, 2013. Shareholders who purchased LLY stock prior to the ex-dividend date are eligible for ...NASDAQ · 5/13/2013
Shares of Eli Lilly (NYSE:LLY) opened today below their pivot of $54.85 and have already reached the first level of support at $54.40. Investors may be interested in a cross of the next downside pivot targets of $54.06 and $53.27. Eli Lilly has overhead ...Comtex Smartrend · ByAmy Schwartz · 1 hour ago
... has experienced some recent setbacks -- diabetes drug Januvia had lackluster sales while asthma drug Singulair saw its patent expire -- there’s reason for optimism. The company has agreements in place with Pfizer …beta.fool.com · 1 day ago
Marketwatch
My colleague Ken Trester at Maximum Options recommended an options trade in this stock earlier this week, and though our approach to picking trades differs, my analysis led me to the same conclusion—pharmaceuticals, particularly LLY, are roaring up.Investor Place · ByJon Markman · 4/3/2013
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - neurology (33.5%): primarily drugs used in treating depression and schizophrenia; - endocrinology (30.1%): products for ...4-traders · 5/22/2013
Judging by the fact that Eli Lilly & Co. (NYSE:LLY) has faced falling interest from hedge fund managers, we can see that there was a specific group of hedgies that slashed their full holdings heading into 2013. At the top of the heap, Andreas Halvorsen's ...INSIDER MONKEY · 3/27/2013
POPULAR NOW
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback